<DOC>
	<DOC>NCT03068208</DOC>
	<brief_summary>Efficacy of Methylene blue mediated Photodynamic therapy for primary localized cutaneous amyloidosis treatment in Asians, pilot study.</brief_summary>
	<brief_title>Efficacy of Methylene Blue Mediated Photodynamic Therapy for Primary Localized Cutaneous Amyloidosis Treatment in Asians</brief_title>
	<detailed_description />
	<mesh_term>Amyloidosis</mesh_term>
	<mesh_term>Skin Diseases, Genetic</mesh_term>
	<mesh_term>Amyloidosis, Familial</mesh_term>
	<mesh_term>Methylene Blue</mesh_term>
	<criteria>Patients, aged &gt; 18 years old with lichen amyloidosis diagnosed by using clinical presentation and pathological findings. Those with systemic disease associated cutaneous amyloidosis Pregnancy or lactating woman Those who are allergic to urea, olive oil Those who are photosensitive to ultraviolet radiation Those who had been previously treated with any of which medications, radiation, laser within 3 months and 1 month for topical therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Methylene blue</keyword>
	<keyword>photodynamic therapy</keyword>
	<keyword>primary cutaneous localized amyloidosis</keyword>
	<keyword>lichen amyloidosis</keyword>
</DOC>